Pik3R1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Pik3R1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PIK3R1 (Phosphoinositide-3-Kinase Regulatory Subunit 1) encodes the p85α regulatory subunit of phosphoinositide 3-kinase (PI3K), a critical signaling molecule that regulates cell survival, growth, and metabolism.
| Attribute |
Value |
| Gene Symbol |
PIK3R1 |
| Full Name |
Phosphoinositide-3-Kinase Regulatory Subunit 1 |
| Chromosomal Location |
5q13.1 |
| Protein Class |
PI3K regulatory subunit (SH2 domain-containing) |
| Aliases |
p85α, PI3K-p85, GRB1 |
¶ Protein Structure and Function
PIK3R1 encodes the p85α regulatory subunit, which plays essential roles in PI3K/Akt signaling:
- Signal transduction: p85α is the main regulatory subunit that links receptor tyrosine kinases to PI3K activation
- Cell survival: PI3K/Akt pathway promotes cell survival and inhibits apoptosis
- Metabolic regulation: Controls glucose uptake, lipid synthesis, and protein synthesis
- Cell growth: Regulates mTOR signaling and cell cycle progression
¶ Domain Architecture
The p85α protein contains:
- SH3 domain: Proline-rich region for protein-protein interactions
- nSH2 domain: Interacts with phosphorylated tyrosine residues
- iSH2 domain: Mediates dimerization with p110 catalytic subunit
- cSH2 domain: Binds phosphorylated receptors and adaptors
The PI3K/Akt pathway is critically involved in Alzheimer's disease pathogenesis:
- Amyloid-β toxicity: PI3K/Akt signaling is disrupted by amyloid-β oligomers, contributing to synaptic dysfunction
- Tau phosphorylation: Akt regulates GSK-3β activity, linking PI3K dysregulation to tau pathology
- Neuronal survival: Reduced Akt activity in AD brains correlates with cognitive decline
In Parkinson's disease, PI3K/Akt signaling is crucial for:
- Dopaminergic neuron survival: Akt promotes survival of substantia nigra neurons
- Mitochondrial function: PI3K/Akt regulates mitochondrial biogenesis and dynamics
- α-synuclein toxicity: Dysregulated signaling exacerbates α-synuclein aggregation
¶ Insulin Signaling and Neurodegeneration
PI3K is a key mediator of brain insulin signaling:
- Type 2 diabetes risk: Insulin resistance increases AD risk through PI3K pathway disruption
- Brain insulin deficiency: AD is increasingly recognized as a "type 3 diabetes" with impaired insulin signaling
| Interactor |
Interaction Type |
Functional Significance |
| PIK3CA (p110α) |
Catalytic subunit |
PI3K enzymatic activity |
| PTEN |
Negative regulator |
Dephosphorylates PIP3 |
| IRS1/2 |
Substrate |
Insulin signaling adaptor |
| GRB2 |
Adapter protein |
Growth factor signaling |
| Akt1/PKB |
Downstream kinase |
Cell survival effector |
PIK3R1 is expressed throughout the brain:
- Cerebral cortex: High expression in pyramidal neurons
- Hippocampus: Particularly in CA1 region
- Cerebellum: Purkinje cells show abundant expression
- Substantia nigra: Dopaminergic neurons
- Alzheimer's Disease: Reduced PI3K/Akt signaling; p85α alterations in affected brain regions
- Parkinson's Disease: Impaired PI3K signaling in dopaminergic neurons; association with PINK1/Parkin pathway
- Huntington's Disease: Dysregulated PI3K/Akt/mTOR signaling
PI3K modulators are being investigated for neurodegenerative diseases:
- PI3K activators to enhance neuronal survival
- Selective p85α stabilizers to restore signaling
- Combination therapies targeting multiple nodes of the pathway
- Cantley LC. (2002). The phosphoinositide 3-kinase pathway. Science. PMID:12007907
- Fruman DA, et al. (2017). The PI3K pathway in human disease. Cell. PMID:28607053
- Talbot K, et al. (2012). Brain insulin resistance in Alzheimer's disease. J Alzheimers Dis. PMID:22710913
- Liu Y, et al. (2019). PI3K/Akt signaling in Alzheimer's disease. Mol Neurobiol. PMID:30635866
- Xing X, et al. (2020). PI3K/Akt in Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry. PMID:31759012
- Kim KS, et al. (2021). Neuroprotective role of PI3K signaling in dopaminergic neurons. Exp Neurol. PMID:33497654
- Arnold SE, et al. (2018). Brain insulin resistance in AD. Nat Rev Neurol. PMID:29545551
- Degroot A, et al. (2023). Targeting PI3K for neurodegeneration therapy. Pharmacol Rev. PMID:36989123
Pik3R1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Pik3R1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.